Skip to main content
Clinical Trials/DRKS00029691
DRKS00029691
Recruiting
未知

Reduction of the risk of dialysis - MinDial

KfH-Stiftung Präventivmedizin,0 sites357 target enrollmentSeptember 12, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
N04
Sponsor
KfH-Stiftung Präventivmedizin,
Enrollment
357
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
KfH-Stiftung Präventivmedizin,

Eligibility Criteria

Inclusion Criteria

  • Health insurance with KNAPPSCHAFT
  • \- Admission to one of the participating hospitals from 20 September 2022
  • \- Existing chronic renal insufficiency (either already known and documented in the KIS by diagnoses such as N17\.99 or N18\.1\-.9, N19, R31, R80\) or detected during hospitalization (\<60 ml/min/1\.73 m² according to CKD\-Epi, as opposed to acute renal failure)
  • \- Risk of end\-stage renal failure within 5 years according to the KFRE score of at least 15% (date of laboratory determination before 20\.06\.2023\) or at least 9% (from 20\.06\.2023\)
  • \- Consent to be contacted after dismissal and to contact the HA/HÄ and the FA/FA

Exclusion Criteria

  • \- Patients with \= 2 consultations with a nephrological specialist in the last 12 months before enrollment
  • \- Included in MinDial during previous hospital stay
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials